Urogen Pharma (URGN)
(Real Time Quote from BATS)
$14.48 USD
+0.33 (2.33%)
Updated Apr 29, 2024 10:10 AM ET
4-Sell of 5 4
F Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.93 |
EPS Last Quarter | -0.72 |
Last EPS Surprise | -7.46% |
ABR | 1.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.59 |
Next Year | -1.75 |
EPS (TTM) | -3.73 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 20.73M | 23.97M | 99.38M | 172.16M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 21.45M | 24.50M | 99.75M | 180.82M |
Low Estimate | 20.00M | 23.44M | 99.00M | 163.50M |
Year ago Sales | 17.19M | 21.14M | 82.71M | 99.38M |
Year over Year Growth Est. | 20.56% | 13.39% | 20.14% | 73.24% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.93 | -0.89 | -3.59 | -1.75 |
# of Estimates | 3 | 2 | 4 | 3 |
Most Recent Consensus | -0.94 | -0.93 | -3.56 | -2.03 |
High Estimate | -0.87 | -0.85 | -3.30 | -0.10 |
Low Estimate | -0.99 | -0.93 | -3.90 | -3.13 |
Year ago EPS | -1.30 | -1.03 | -3.55 | -3.59 |
Year over Year Growth Est. | 28.46% | 13.59% | -1.13% | 51.23% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 2 | 4 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.93 | -0.89 | -3.59 | -1.75 |
7 Days Ago | -0.93 | -0.89 | -3.59 | -1.75 |
30 Days Ago | -0.93 | -0.89 | -3.59 | -1.75 |
60 Days Ago | -0.73 | -0.69 | -2.66 | -1.96 |
90 Days Ago | -0.73 | -0.69 | -2.66 | -1.96 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.93 | -0.89 | -3.59 | -1.75 |
Zacks Consensus Estimate | -0.93 | -0.89 | -3.59 | -1.75 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.72 | -0.68 | -1.03 | -1.30 | NA |
Estimate | -0.67 | -0.89 | -1.13 | -1.39 | NA |
Difference | -0.05 | 0.21 | 0.10 | 0.09 | 0.09 |
Surprise | -7.46% | 23.60% | 8.85% | 6.47% | 7.87% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more